BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9077605)

  • 1. Early prenatal diagnosis of triploidy.
    Jauniaux E; Brown R; Snijders RJ; Noble P; Nicolaides KH
    Am J Obstet Gynecol; 1997 Mar; 176(3):550-4. PubMed ID: 9077605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy.
    Schmidt D; Shaffer LG; McCaskill C; Rose E; Greenberg F
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):77-80. PubMed ID: 7507646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal sonographic features of triploidy at 12-16 weeks.
    Zalel Y; Shapiro I; Weissmann-Brenner A; Berkenstadt M; Leibovitz Z; Bronshtein M
    Prenat Diagn; 2016 Jul; 36(7):650-5. PubMed ID: 27135789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of triploidy at 11-14 weeks' gestation: a cohort study of 198 000 pregnant women.
    Engelbrechtsen L; Brøndum-Nielsen K; Ekelund C; Tabor A; Skibsted L;
    Ultrasound Obstet Gynecol; 2013 Nov; 42(5):530-5. PubMed ID: 23494847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal sonographic features can accurately determine parental origin in triploid pregnancies.
    Lugthart MA; Horenblas J; Kleinrouweler EC; Engels M; Knegt AC; Huijsdens K; van Leeuwen E; Pajkrt E
    Prenat Diagn; 2020 May; 40(6):705-714. PubMed ID: 32039494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
    Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of triploidy. A case report.
    Del Valle GO; Izquierdo LA; Joffe GM; Smith JF; Gilson GJ; Chatterjee MS; Curet LB
    J Reprod Med; 1992 Apr; 37(4):360-2. PubMed ID: 1593562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triploid pregnancies: genetic and clinical features of 158 cases.
    Joergensen MW; Niemann I; Rasmussen AA; Hindkjaer J; Agerholm I; Bolund L; Sunde L
    Am J Obstet Gynecol; 2014 Oct; 211(4):370.e1-19. PubMed ID: 24657790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin.
    Yaron Y; Ochshorn Y; Tsabari S; Shira AB
    Prenat Diagn; 2004 Jun; 24(6):445-50. PubMed ID: 15229844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Triploidies].
    Jambon AC; Tillouche N; Valat AS; Guionnet B; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 1998 Jan; 27(1):35-43. PubMed ID: 9583043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of karyotype to embryo crown-rump length and maternal serum human chorionic gonadotropin level in early miscarriage.
    Liu Y; Liu Y; Chen H; Li Q; Meng L; Chen L; Du T; Zhang J
    Am J Perinatol; 2015 Jan; 32(1):15-22. PubMed ID: 24705969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal heart rate in chromosomally abnormal fetuses.
    Liao AW; Snijders R; Geerts L; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2000 Dec; 16(7):610-3. PubMed ID: 11169365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness.
    Jauniaux E; Gavrill P; Khun P; Kurdi W; Hyett J; Nicolaides KH
    Hum Reprod; 1996 Feb; 11(2):435-9. PubMed ID: 8671238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
    Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
    Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.